持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/03/29 | 1,204 | 1,216 | 1,198 | 1,215 | +2 | +0.2% | 121,000 |
| 2013/03/28 | 1,229 | 1,234 | 1,191 | 1,213 | -24 | -1.9% | 217,000 |
| 2013/03/27 | 1,221 | 1,243 | 1,219 | 1,237 | -27 | -2.1% | 124,000 |
| 2013/03/26 | 1,230 | 1,269 | 1,230 | 1,264 | +13 | +1% | 166,000 |
| 2013/03/25 | 1,226 | 1,257 | 1,214 | 1,251 | -5 | -0.4% | 344,000 |
| 2013/03/22 | 1,258 | 1,316 | 1,255 | 1,256 | -13 | -1% | 429,000 |
| 2013/03/21 | 1,235 | 1,276 | 1,235 | 1,269 | +30 | +2.4% | 312,000 |
| 2013/03/19 | 1,221 | 1,250 | 1,221 | 1,239 | +18 | +1.5% | 242,000 |
| 2013/03/18 | 1,209 | 1,241 | 1,181 | 1,221 | +18 | +1.5% | 288,000 |
| 2013/03/15 | 1,168 | 1,219 | 1,167 | 1,203 | +44 | +3.8% | 268,000 |
| 2013/03/14 | 1,154 | 1,165 | 1,147 | 1,159 | +9 | +0.8% | 118,000 |
| 2013/03/13 | 1,142 | 1,157 | 1,137 | 1,150 | +8 | +0.7% | 162,000 |
| 2013/03/12 | 1,145 | 1,159 | 1,136 | 1,142 | -3 | -0.3% | 218,000 |
| 2013/03/11 | 1,146 | 1,155 | 1,136 | 1,145 | -2 | -0.2% | 204,000 |
| 2013/03/08 | 1,145 | 1,152 | 1,141 | 1,147 | -2 | -0.2% | 351,000 |
| 2013/03/07 | 1,151 | 1,170 | 1,132 | 1,149 | -23 | -2% | 226,000 |
| 2013/03/06 | 1,171 | 1,191 | 1,163 | 1,172 | +6 | +0.5% | 106,000 |
| 2013/03/05 | 1,165 | 1,175 | 1,155 | 1,166 | +23 | +2% | 195,000 |
| 2013/03/04 | 1,143 | 1,171 | 1,141 | 1,143 | +9 | +0.8% | 164,000 |
| 2013/03/01 | 1,123 | 1,143 | 1,111 | 1,134 | +11 | +1% | 109,000 |
| 2013/02/28 | 1,089 | 1,124 | 1,084 | 1,123 | +51 | +4.8% | 239,000 |
| 2013/02/27 | 1,098 | 1,115 | 1,069 | 1,072 | -35 | -3.2% | 350,000 |
| 2013/02/26 | 1,110 | 1,118 | 1,096 | 1,107 | -20 | -1.8% | 137,000 |
| 2013/02/25 | 1,120 | 1,136 | 1,119 | 1,127 | ±0 | ±0% | 139,000 |
| 2013/02/22 | 1,135 | 1,139 | 1,103 | 1,127 | -20 | -1.7% | 115,000 |
| 2013/02/21 | 1,150 | 1,169 | 1,145 | 1,147 | -4 | -0.3% | 64,000 |
| 2013/02/20 | 1,133 | 1,164 | 1,133 | 1,151 | +19 | +1.7% | 101,000 |
| 2013/02/19 | 1,130 | 1,140 | 1,120 | 1,132 | +13 | +1.2% | 48,000 |
| 2013/02/18 | 1,085 | 1,137 | 1,085 | 1,119 | +34 | +3.1% | 206,000 |
| 2013/02/15 | 1,090 | 1,090 | 1,072 | 1,085 | -6 | -0.5% | 171,000 |
| 2013/02/14 | 1,114 | 1,122 | 1,090 | 1,091 | -35 | -3.1% | 129,000 |
| 2013/02/13 | 1,138 | 1,153 | 1,112 | 1,126 | -9 | -0.8% | 90,000 |
| 2013/02/12 | 1,127 | 1,155 | 1,127 | 1,135 | +13 | +1.2% | 109,000 |
| 2013/02/08 | 1,139 | 1,139 | 1,122 | 1,122 | -17 | -1.5% | 114,000 |
| 2013/02/07 | 1,149 | 1,149 | 1,130 | 1,139 | -23 | -2% | 127,000 |
| 2013/02/06 | 1,168 | 1,177 | 1,159 | 1,162 | -2 | -0.2% | 92,000 |
| 2013/02/05 | 1,142 | 1,179 | 1,142 | 1,164 | +21 | +1.8% | 153,000 |
| 2013/02/04 | 1,166 | 1,172 | 1,138 | 1,143 | -22 | -1.9% | 99,000 |
| 2013/02/01 | 1,183 | 1,183 | 1,160 | 1,165 | -6 | -0.5% | 72,000 |
| 2013/01/31 | 1,170 | 1,179 | 1,151 | 1,171 | -9 | -0.8% | 137,000 |
| 2013/01/30 | 1,166 | 1,182 | 1,162 | 1,180 | +14 | +1.2% | 70,000 |
| 2013/01/29 | 1,182 | 1,186 | 1,159 | 1,166 | -8 | -0.7% | 143,000 |
| 2013/01/28 | 1,194 | 1,201 | 1,171 | 1,174 | -20 | -1.7% | 127,000 |
| 2013/01/25 | 1,170 | 1,197 | 1,162 | 1,194 | +21 | +1.8% | 189,000 |
| 2013/01/24 | 1,124 | 1,175 | 1,121 | 1,173 | +48 | +4.3% | 255,000 |
| 2013/01/23 | 1,125 | 1,134 | 1,110 | 1,125 | -1 | -0.1% | 150,000 |
| 2013/01/22 | 1,131 | 1,140 | 1,114 | 1,126 | -5 | -0.4% | 95,000 |
| 2013/01/21 | 1,126 | 1,135 | 1,117 | 1,131 | +2 | +0.2% | 69,000 |
| 2013/01/18 | 1,133 | 1,144 | 1,128 | 1,129 | +7 | +0.6% | 86,000 |
| 2013/01/17 | 1,130 | 1,136 | 1,105 | 1,122 | -11 | -1% | 117,000 |
2851～
2900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
